GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Price-to-Operating-Cash-Flow

AZN (AstraZeneca) Price-to-Operating-Cash-Flow : 20.08 (As of Oct. 31, 2024)


View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Price-to-Operating-Cash-Flow?

As of today (2024-10-31), AstraZeneca's share price is $71.14. AstraZeneca's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $3.54. Hence, AstraZeneca's Price-to-Operating-Cash-Flow Ratio for today is 20.08.

The historical rank and industry rank for AstraZeneca's Price-to-Operating-Cash-Flow or its related term are showing as below:

AZN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.35   Med: 24.56   Max: 74.84
Current: 19.49

During the past 13 years, AstraZeneca's highest Price-to-Operating-Cash-Flow Ratio was 74.84. The lowest was 12.35. And the median was 24.56.

AZN's Price-to-Operating-Cash-Flow is ranked worse than
55.34% of 674 companies
in the Drug Manufacturers industry
Industry Median: 17.94 vs AZN: 19.49

AstraZeneca's Cash Flow from Operations per share for the three months ended in Jun. 2024 was $0.99. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $3.54.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of AstraZeneca was 3.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 24.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 30.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 4.60% per year.

During the past 13 years, AstraZeneca's highest 3-Year average Operating Cash Flow per Share Growth Rate was 43.70% per year. The lowest was -19.80% per year. And the median was 7.60% per year.


AstraZeneca Price-to-Operating-Cash-Flow Historical Data

The historical data trend for AstraZeneca's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Price-to-Operating-Cash-Flow Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.69 26.94 27.62 21.73 20.26

AstraZeneca Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.69 20.55 20.26 21.62 21.99

Competitive Comparison of AstraZeneca's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - General subindustry, AstraZeneca's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Price-to-Operating-Cash-Flow falls into.



AstraZeneca Price-to-Operating-Cash-Flow Calculation

AstraZeneca's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=71.14/3.543
=20.08

AstraZeneca's Share Price of today is $71.14.
AstraZeneca's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

AstraZeneca Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

AstraZeneca Headlines

From GuruFocus

AstraZeneca's H1 and Q2 2024 Financial Results

By Business Wire 07-25-2024